Sana Biotechnology SANA
$ 1.66
3.44%
Quarterly report 2024-Q3
added 11-08-2024
Sana Biotechnology Income Statement 2011-2024 | SANA
Annual Income Statement Sana Biotechnology
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
1.97 B | 614 M | 1.46 B | 42.4 M | - | - | - | - | - | - | - | - | - |
Shares |
195 M | 188 M | 166 M | 13 M | - | - | - | - | - | - | - | - | - |
Historical Prices |
10.1 | 3.26 | 8.76 | - | - | - | - | - | - | - | - | - | - |
Net Income |
-283 M | -269 M | -356 M | -285 M | -131 M | - | - | - | - | - | - | - | - |
Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-293 M | -273 M | -357 M | -286 M | -141 M | - | - | - | - | - | - | - | - |
Interest Expense |
-52 K | -674 K | 305 K | 97 K | -29 K | - | - | - | - | - | - | - | - |
EBITDA |
-269 M | -257 M | -346 M | -280 M | -139 M | - | - | - | - | - | - | - | - |
Operating Expenses |
293 M | 273 M | 357 M | 286 M | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
73.3 M | 71.6 M | 50.4 M | 28.3 M | 21.8 M | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Income Statement Sana Biotechnology
2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
235 M | 234 M | 217 M | 198 M | 197 M | 193 M | 191 M | 191 M | 189 M | 188 M | 186 M | 185 M | 182 M | 180 M | 119 M | 16.2 M | 13.7 M | 12.2 M | 10.8 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income |
-59.9 M | -50.3 M | -107 M | - | 984 K | -114 M | -82.1 M | - | -85.1 M | -72.5 M | -31.4 M | - | -83.3 M | 18.7 M | -181 M | - | -51.5 M | -87.8 M | -32.9 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-61.8 M | -49.4 M | -111 M | - | -2.18 M | -116 M | -84.1 M | - | -86.2 M | -72.9 M | -31.7 M | - | -83.4 M | 18.6 M | -181 M | - | -51.6 M | -87.9 M | -33.3 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expense |
-742 K | -4.12 M | 215 K | - | 303 K | -84 K | -47 K | - | -106 K | -198 K | -102 K | - | 10 K | 1 K | 13 K | - | 44 K | 19 K | 5 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
-57.7 M | -45.5 M | -107 M | - | 2.32 M | -112 M | -79.8 M | - | -82.2 M | -69.1 M | -28.1 M | - | -80.6 M | 21.2 M | -179 M | - | -50 M | -86.5 M | -32 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses |
61.8 M | 49.4 M | 111 M | - | 2.18 M | 116 M | 84.1 M | - | 86.2 M | 72.9 M | 31.7 M | - | 83.4 M | - | 181 M | - | 51.6 M | - | 33.3 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
14.1 M | 16.4 M | 16.3 M | - | 19.2 M | 16.6 M | 16.8 M | - | 15.5 M | 18.3 M | 14.4 M | - | 13.4 M | 12.5 M | 11.8 M | - | 7.1 M | 6.01 M | 5.96 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency